Back to
Bank Julius Baer & Co. Ltd, Zurich
INO
Showing 0 of 6 quarters
Position history for
Bank Julius Baer & Co. Ltd, Zurich's holdings in INOVIO PHARMACEUTICALS INC
No. Bank Julius Baer & Co. Ltd, Zurich exited its INO (Inovio Pharmaceuticals) position in Q2 2021. Its Q1 2021 13F listed 2,500 shares worth $23,000. Bank Julius Baer & Co. Ltd, Zurich already held INO in its Q1 2020 13F, the earliest on record, and held it in 5 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.